A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study is a phase 2, multicenter, double-blind, randomized, placebo controlled, parallel-group study to investigate the renal safety and tolerability of multiple dose intravenous (IV) administration of CSL112 compared with placebo in subjects with moderate renal impairment (RI) and acute myocardial infarction (AMI).
Epistemonikos ID: 93baaf0da9a633489b60918a2dbf1c2e698e4068
First added on: May 12, 2024